New York recalls
4,067 federal recalls affecting New York in the last 12 months - 419 New York-specific plus 3,648 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-09-02FDA-DrugAccord HealthcareClass IINationwideAccord levothyroxine 200 mcg tablets recalled for subpotency
Accord Healthcare is recalling specific lots of levothyroxine sodium 200 mcg tablets because they contain less active ingredient than labeled. This means the medication may not work as intended for patients taking it to treat thyroid conditions.
- 2026-09-02FDA-DrugAccord HealthcareClass IINationwideAccord Healthcare Levothyroxine 175 mcg recalled for subpotency
Accord Healthcare is recalling specific lots of Levothyroxine Sodium Tablets 175 mcg because they may contain less active ingredient than labeled. Levothyroxine is a thyroid hormone replacement medication, and tablets that are weaker than expected could result in inadequate treatment of thyroid conditions.
- 2026-09-02FDA-DrugAccord HealthcareClass IINationwideAccord levothyroxine tablets recalled for being subpotent
Accord Healthcare is recalling specific lots of levothyroxine sodium 150 mcg tablets because they may contain less active ingredient than labeled. Levothyroxine is a thyroid replacement medication, and subpotent tablets could result in inadequate thyroid hormone levels in patients who depend on this drug.
- 2026-09-02FDA-DrugAccord HealthcareClass IINationwideAccord Healthcare levothyroxine tablets recalled for lower potency
Accord Healthcare is recalling certain batches of levothyroxine sodium 137 mcg tablets because they contain less active ingredient than labeled. Levothyroxine is a thyroid medication, and tablets that are weaker than expected may not effectively treat hypothyroidism. The recall affects 90-count and 1000-count bottles distributed nationwide.
- 2026-09-02FDA-DrugAccord HealthcareClass IINationwideAccord Levothyroxine 125 mcg tablets recalled for reduced potency
Accord Healthcare is recalling specific lots of Levothyroxine Sodium 125 mcg tablets because they may contain less active ingredient than labeled. This means the medication may not work as intended for patients taking it to manage thyroid conditions.
- 2026-09-02FDA-DrugAccord HealthcareClass IINationwideAccord Healthcare levothyroxine tablets recalled for reduced potency
Accord Healthcare is recalling specific lots of levothyroxine sodium 112 mcg tablets because they contain less active ingredient than labeled. This means patients taking these tablets may not receive the full thyroid hormone dose they need. The recall affects 1000-count bottles distributed nationwide.
- 2026-09-02FDA-DrugAccord HealthcareClass IINationwideAccord levothyroxine tablets recalled for subpotency risk
Accord Healthcare is recalling certain batches of levothyroxine sodium 100 mcg tablets because they may contain less active ingredient than labeled. This affects patients who rely on consistent thyroid hormone dosing. The affected lots were distributed nationwide.
- 2026-09-02FDA-DrugAccord HealthcareClass IINationwideAccord levothyroxine tablets recalled for subpotent drug
Accord Healthcare is recalling certain batches of levothyroxine sodium 88 mcg tablets because they may contain less active ingredient than labeled. This means the medication may not work as intended for patients who depend on it to manage thyroid conditions.
- 2026-09-02FDA-DrugAccord HealthcareClass IINationwideAccord Healthcare levothyroxine tablets recalled for reduced potency
Accord Healthcare is recalling specific lots of levothyroxine sodium 75 mcg tablets because the tablets contain less active ingredient than labeled. Levothyroxine is a thyroid hormone replacement medication, and subpotent doses may not adequately treat thyroid conditions. The affected lots are D2402016 and D2402017, expiring 08/31/2026.
- 2026-09-02FDA-DrugAccord HealthcareClass IINationwideAccord levothyroxine tablets recalled for subpotent content
Accord Healthcare is recalling specific lots of levothyroxine sodium 50 mcg tablets because they contain less active ingredient than labeled. This means the medication may not work as intended for patients who depend on it to manage thyroid conditions.
- 2026-09-02FDA-DrugAccord HealthcareClass IINationwideAccord Healthcare levothyroxine tablets recalled for subpotency
Accord Healthcare is recalling specific lots of levothyroxine sodium tablets (25 mcg) because they contain less active ingredient than labeled. Patients taking these tablets may not receive the full dose needed to manage their thyroid condition. The affected lots were distributed nationwide.
- 2026-08-29FDA-PRNorthwest NaturalsNationwideNorthwest Naturals pet food recalled for Salmonella, Listeria risk
Northwest Naturals has recalled two frozen raw pet food products because they may be contaminated with Salmonella and/or Listeria monocytogenes. The affected products are the Frozen Chicken Recipe (cat food, 2 lb. bags) and Frozen Raw Diet for Dogs Chicken Recipe (6 lb. bags) in specific lots. No illnesses have been reported so far.
- 2026-08-27FDA-PRB. BraunNationwideB. Braun saline injection recalled for particulate contamination
B. Braun Medical Inc. is recalling three lots of 0.9% Sodium Chloride Injection (saline solution) used in hospitals and healthcare settings. The recalled product contains particles of zinc oxide that should not be present. Intravenous fluids contaminated with particulate matter can cause serious complications including blood clots and organ damage. No injuries have been reported so far.
- 2026-08-27FDA-PRLipofitNationwideLipofit Extreme Fat Burner recalled for hidden prescription drug and toxic substance
Lipofit Extreme Fat Burner 2.0 (Lot 25M12F, expiration 09/2027) contains undeclared fluoxetine, a prescription antidepressant, in the daytime tablets and undeclared 2,4-dinitrophenol (DNP), a toxic pesticide, in the nighttime tablets. Neither ingredient is approved for use in dietary supplements, and DNP is not approved by the FDA for any use in humans.
- 2026-08-26FDA-PRRevival Animal HealthNationwideBreeder's Edge and Shelter's Choice kitten milk recalled for nutrient deficiency
Revival Animal Health recalled Breeder's Edge® and Shelter's Choice® Feline Milk Replacers because some batches contain low levels of potassium, copper, folic acid, choline, and/or vitamin B6. Young kittens depend entirely on milk replacer for nutrition, and these deficiencies can cause anemia, organ damage, and developmental problems within days or weeks.
- 2026-08-26FDA-PRBaxterNationwideBaxter sodium citrate solution recalled for fiberglass contamination
Baxter is recalling one lot of Anticoagulant Sodium Citrate Solution used with apheresis devices due to potential fiberglass particles in the solution. The affected product was distributed to one customer in the United States between July 2 and July 11, 2026. No adverse events have been reported to date.
- 2026-08-26FDA-FoodLidlClass IVitasia Wok Spice Mix recalled for Salmonella risk
Lidl US is recalling Vitasia Asian Style Wok Spice Mix after a positive test for Salmonella bacteria. The affected product is the 1.58 oz (45g) package with lot number 155846 and best-if-used-by date of June 2028. This spice mix was sold in Washington DC, Delaware, Georgia, Maryland, North Carolina, New Jersey, New York, Pennsylvania, South Carolina, and Virginia.
- 2026-08-26FDA-FoodCoast Citrus DistributorsClass INationwideCoast Citrus jalapeno peppers recalled for Salmonella risk
Coast Citrus Distributors is recalling bulk jalapeno peppers packaged between July 1–31, 2026, due to potential Salmonella Javiana contamination. The peppers were distributed in bulk containers to wholesale distributors across the central and eastern United States, with further nationwide distribution for food processing. No retail packages or consumer illnesses have been identified.
- 2026-08-26FDA-FoodProspector PopcornClass IIIProspector Popcorn Belgian Chocolate Toffee recalled for mislabeled nutrients
Prospector Popcorn Belgian Chocolate Toffee Gourmet Popcorn 3.5oz packages have inaccurate nutrition information on the label. Iron content is understated and Vitamin D content is overstated. The affected products have best-by dates on or before July 10, 2027, with UPC 850073852125.
- 2026-08-26FDA-FoodProspector PopcornClass IIIProspector Popcorn Fudge Brownie recalled for mislabeled nutrients
Prospector Popcorn Fudge Brownie Gourmet Popcorn (1.5 oz and 3.5 oz packages) has inaccurate nutrition labels. The stated amounts of Potassium and Calcium are overstated on the package. No injuries have been reported.
- 2026-08-26FDA-FoodProspector PopcornClass IIIProspector Popcorn recalled for inaccurate nutrition label
Prospector Popcorn Maple Walnut Ice Cream Gourmet Popcorn 3.5 oz. packages have nutrition labels with incorrect values. Potassium and Calcium are overstated, while Iron is understated. This affects anyone with dietary restrictions or conditions requiring careful nutrient tracking.
- 2026-08-26FDA-FoodProspector PopcornClass IIProspector Popcorn Chocolate Mocha recalled for mislabeled nutrients
Prospector Popcorn Chocolate Mocha Gourmet Popcorn 1.5 oz. packages have inaccurate nutrition information on the label. Carbohydrates and cholesterol are understated. The affected products have a Best By date on or before July 10, 2027.
- 2026-08-26FDA-DrugAmerican RegentClass IINationwideAmerican Regent niCARdipine injection recalled for particulate matter
American Regent's niCARdipine Hydrochloride Injection (25 mg/10mL) has been recalled due to contamination with particulate matter, including hair, glass, and/or paraformaldehyde. The affected lot (25295N0C0, expiring 04/30/2027) was distributed nationwide and affects approximately 43,460 vials.
- 2026-08-26FDA-DrugAmerican RegentClass IINationwideAmerican Regent Tralement injection recalled for particulate matter
American Regent's Tralement (trace elements injection) contains particulate matter including hair, glass, and/or paraformaldehyde. The contamination affects specific lots with expiration dates in April and September 2027. This is a prescription medication used in clinical settings.
- 2026-08-26FDA-DrugAmerican RegentClass INationwideAmerican Regent Papaverine HCl Injection recalled for particulate contamination
American Regent's Papaverine HCl Injection (60 mg/2 mL) has been found to contain particulate matter identified as glass and/or paraformaldehyde. The contamination affects one lot (25202, expiring 11/30/2026) distributed nationwide. This is a prescription injectable medication used to treat certain circulatory conditions.
- 2026-08-26FDA-DrugAmerican RegentClass IINationwideAmerican Regent Multrys injection recalled for particulate contamination
American Regent is recalling Multrys (Trace Elements Injection 4, USP) due to contamination with particulate matter, including hair, glass, and/or paraformaldehyde. The contamination was identified in specific lot 25163 (expiration 4/30/2027). This is a prescription intravenous medication used in hospitals and clinical settings.
- 2026-08-26FDA-DrugAmerican RegentClass IINationwideAmerican Regent Selenious Acid Injection recalled for contamination
American Regent's Selenious Acid Injection (a trace mineral used in intravenous nutrition) has been recalled because some vials contain particulate matter, including hair, glass, and/or paraformaldehyde. The contamination affects specific lot numbers distributed nationwide.
- 2026-08-26FDA-DrugAmerican RegentClass IINationwideAmerican Regent acetylcysteine solution recalled for particulate contamination
American Regent's acetylcysteine solution (20%, 200 mg/mL) in 4 mL vials has been found to contain particulate matter including hair, glass, and/or paraformaldehyde. The contamination affects two lots distributed nationwide. This is a prescription-only inhalation medication.
- 2026-08-26FDA-DrugAmerican RegentClass IINationwideAmerican Regent acetylcysteine solution recalled for particulate contamination
American Regent's acetylcysteine solution (10%, 100 mg/mL) in 4 mL vials has been found to contain particulate matter, including hair, glass, and/or paraformaldehyde. The contamination affects three specific lots distributed nationwide. This is a prescription medication for inhalation use only.
- 2026-08-26FDA-DrugAmerican RegentClass IINationwideAmerican Regent Atropine Sulfate injection recalled for contamination
American Regent's Atropine Sulfate injection (1 mg/mL) has been found to contain particulate matter, including hair, glass, and/or paraformaldehyde. The contamination affects specific lot 24353 (expiration 9/30/2026). This is a prescription injectable medication used in hospitals and clinical settings.
Get notified about new New York recalls
Free weekly digest. Add New York to your profile to filter alerts to your state.